Is yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings?

Is yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings?

<h4>Objective</h4>Patients living with rheumatologic diseases on disease-modifying antirheumatic drugs (DMARD) are at an increased risk of developing tuberculosis (TB). Current guidelines recommend screening for latent tuberculosis infection (LTBI) before initiating DMARD. However, data...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Carlo Foppiano Palacios, Vaidehi Chowdhary, Ritche Hao, Abhijeet Danve, Maricar Malinis
Natura:	Articolo
Lingua:	English
Pubblicazione:	Public Library of Science (PLoS) 2024-01-01
Serie:	PLoS ONE
Accesso online:	https://doi.org/10.1371/journal.pone.0306337

Documenti analoghi

Efficacy of an 8-week course of sofosbuvir and ledipasvir for the treatment of HCV infection in selected HIV-infected patients [version 2; referees: 2 approved]
di: Onyema Ogbuagu, et al.
Pubblicazione: (2018-09-01)

Interferon-gamma release assays for diagnosis of latent TB infection in chronic kidney diseases and dialysis patients
di: Pattorn Hayuk, et al.
Pubblicazione: (2022-11-01)

Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.
di: Tan N Doan, et al.
Pubblicazione: (2017-01-01)

The Role of Interferon-Gamma Release Assays in Diagnosis of Latent Tuberculosis Infection in Children
di: Mateja Šegović, et al.
Pubblicazione: (2023-01-01)

Risk stratification of latent tuberculosis defined by combined interferon gamma release assays.
di: Véronique Corbière, et al.
Pubblicazione: (2012-01-01)

Concordance between tuberculin skin test and interferon-gamma release assay for latent tuberculosis screening in inflammatory bowel disease
di: Saad Alrajhi, et al.
Pubblicazione: (2020-07-01)

Assessment of an Interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patients
di: M Hoffmann, et al.
Pubblicazione: (2010-05-01)

Interferon gamma release assays for detection of latent Mycobacterium tuberculosis in older Hispanic people
di: Julia M. Scordo, et al.
Pubblicazione: (2021-10-01)

Can interferon-gamma or interferon-gamma-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas?
di: Mohammed Ahmed Yassin, et al.
Pubblicazione: (2011-01-01)

Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
di: Karan Sachdeva, et al.
Pubblicazione: (2023-04-01)

Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants
di: O'Shea, M, et al.
Pubblicazione: (2014)

Role of interferon-gamma release assay for screening and monitoring of latent tuberculosis infection in kidney transplant recipients
di: Jackrapong Bruminhent, et al.
Pubblicazione: (2024-10-01)

Screening for Latent Tuberculosis Infection using Interferon-Gamma Release Assay Test among Healthcare Workers
di: Rosamarlina Rosamarlina, et al.
Pubblicazione: (2023-08-01)

Predictors for False-Negative Interferon-Gamma Release Assay Results in Hemodialysis Patients with Latent Tuberculosis Infection
di: Heechul Park, et al.
Pubblicazione: (2022-12-01)

Chest roentgenography is complementary to interferon-gamma release assay in latent tuberculosis infection screening of rheumatic patients
di: Ping-Huai Wang, et al.
Pubblicazione: (2020-08-01)

Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
di: Matthew K O'Shea, et al.
Pubblicazione: (2014-01-01)

Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon gamma release assays
di: Mwananyanda Lawrence, et al.
Pubblicazione: (2011-09-01)

Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence
di: A. Trajman, et al.
Pubblicazione: (2013-01-01)

Evaluation of a New Chemiluminescent Immunoassay-Based Interferon-Gamma Release Assay for Detection of Latent Tuberculosis Infection
di: Keun Ju Kim, et al.
Pubblicazione: (2023-09-01)

Distinguishing Latent from Active Mycobacterium tuberculosis Infection Using Elispot Assays: Looking Beyond Interferon-gamma
di: Jennifer E. Snyder-Cappione, et al.
Pubblicazione: (2012-05-01)

Utility of the interferon-gamma release assay for latent tuberculosis infection screening among indian health-care workers
di: Sunita Girish, et al.
Pubblicazione: (2021-01-01)

Elevated Circulating Concentrations of Interferon-Gamma in Latent Tuberculosis Infection
di: Moises Arturo Huaman, et al.
Pubblicazione: (2016-11-01)

Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis
di: Guozhong Zhou, et al.
Pubblicazione: (2023-05-01)

Role of interferon-gamma release assays (IGRAs) for the screening of latent tuberculosis infection in patients candidates for TNF-α antagonist
di: Ilaria Sauzullo, et al.
Pubblicazione: (2010-06-01)

Comparison of two interferon gamma release assays in the diagnosis of <it>Mycobacterium tuberculosis </it>infection and disease in The Gambia
di: Donkor Simon, et al.
Pubblicazione: (2007-10-01)

Performance of the Interferon Gamma Release Assays in Tuberculosis Disease in Children Five Years Old or Less.
di: Lin Sun, et al.
Pubblicazione: (2015-01-01)

Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country.
di: Clíona Ní Cheallaigh, et al.
Pubblicazione: (2013-01-01)

Comparison of interferon gamma release assay and tuberculin skin test for diagnosis of latent tuberculosis in psoriasis patients planned for systemic therapy
di: Shekhar Neema, et al.
Pubblicazione: (2022-01-01)

Interferon-gamma release assay for the diagnosis of latent TB infection--analysis of discordant results, when compared to the tuberculin skin test.
di: Albert Nienhaus, et al.
Pubblicazione: (2008-01-01)

Performance of LTBI Screening in Patients with Rheumatic Diseases Using Two Different Interferon-Gamma Releasing Assays
di: Le Zhang, et al.
Pubblicazione: (2022-10-01)

Diagnosis of latent tuberculosis among HIV infected patients in Ilorin, Nigeria using tuberculin skin test and interferon gamma release assay
di: Adeniyi Olatunji Aladesanmi, et al.
Pubblicazione: (2021-01-01)

Performance evaluation of newly developed fluorescence immunoassay-based interferon-gamma release assay for the diagnosis of latent tuberculosis infection in healthcare workers
di: Oh Joo Kweon, et al.
Pubblicazione: (2022-04-01)

Gamma-delta T-cell large granular lymphocytic leukemia in the setting of rheumatologic diseases
di: Vadim Gorodetskiy, et al.
Pubblicazione: (2024-08-01)

Interferon-gamma release assay for screening of tuberculosis infection in children
di: Huiwen Zheng, et al.
Pubblicazione: (2023-12-01)

Diagnostic performance of interferon-Gamma assay for tuberculosis in immunocompromised patients
di: Shih-Yang Su, et al.
Pubblicazione: (2013-01-01)

The Benefit of Interferon-Gamma Release Assay for Diagnosis of Extrapulmonary Tuberculosis
di: Cleopas Martin Rumende, et al.
Pubblicazione: (2018-06-01)

Interferon-gamma release assay performance in pulmonary and extrapulmonary tuberculosis.
di: Yun Feng, et al.
Pubblicazione: (2012-01-01)

Warrants fundamentals and factors affecting warrant pricing
di: Low, Sharon Wan Kein, et al.
Pubblicazione: (2015)

Warrant, Conclusive Reason, and Failure-Of-Transfer-Of-Warrant
di: Murali Ramachandran
Pubblicazione: (2018-10-01)

Interferon Gamma in Sickness Predisposing to Mycobacterial Infectious Diseases
di: Betül Gemici Karaaslan, et al.
Pubblicazione: (2024-09-01)